Overview

Use of Ziv Aflibercept in Different Retinal Diseases

Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
A prospective interventional case series study was conducted on 20 eyes of 20 patients with active myopic choroidal neovascularisation (CNV) ,20 eyes with resistant diabetic macular edema and 15 eyes with non ischaemic central retinal vein occlusion(CRVO) after approval of the Ethical Committee of the Faculty of Medicine, Tanta University . All procedures were carried out under the tenets of the Helsinki Declaration. Written consent was provided by all participants after discussing the procedure, alternative treatment plans, follow-up schedules, and possible benefits and risks.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Amin El Sayed Nawar
Collaborator:
Tanta University
Treatments:
Aflibercept